ELISA F29 -A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment.

• Main Authors: Rocio Rivero (Author), Mónica Inés Esteva (Author), Erya Huang (Author), Leylen Colmegna (Author), Jaime Altcheh (Author), Ulrike Grossmann (Author), Andrés Mariano Ruiz (Author), CHICO and CHICO SECURE Study Groups (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>Measurement of the success of antitrypanosomal treatment for Chagas disease is difficult, particularly in the chronic phase of the disease, because anti-Trypanosoma cruzi antibodies persist in serum for prolonged periods. We studied the effects of nifurtimox administer...